Monthly Communication Report

Corporation:	Pfizer Canada ULC
Associated registration:	960525-15283-42
Communication date:	2025-09-11
Posted date:	2025-10-15

Designated Public Office Holders who participated in the communication:	Lisa Xie, Policy Advisor Office of the Minister, Innovation, Science and Economic Development Canada (ISED) Manuela Tomic, Senior Advisor Office of the Minister, Innovation, Science and Economic Development Canada (ISED)
List of Details Subject matter Detail Federal-Provincial Relations, Government Procurement, Health, Industry, Intellectual Property, International Trade, Research and Development, Taxation and Finance Advocacy on the creation of the Health Emergency Readiness Canada (HERC) Agency Intellectual Property, International Trade Advocacy on the proposed Regulations Amending the Patent Rules and Certain Regulations Made Under the Patent Act which were published for consultation in Canada Gazette Part I (CGI) on May 18, 2024.1 Share concerns with Canada’s implementation of a patent term adjustment (PTA) system that is not compliant with its trade obligations, as it does not provide a meaningful remedy to patentees who are impacted by unreasonable patent office delays. Federal-Provincial Relations, Foreign Affairs, Government Procurement, Health, International Trade, Research and Development, Taxation and Finance Advocacy with respect to Canada's proposed Countermeasures in Response to United States Tariffs on Canadian goods Health, Industry, Intellectual Property, International Trade, Research and Development Contribution to the Government Public consultations on Canada-United States-Mexico Agreement to inform Canada’s priorities in preparation for the first joint review of CUSMA by Canada, the United States and Mexico in 2026 and ahead of Canada’s chairing of the 5th meeting of the CUSMA Free Trade Commission, in 2025. Health, Industry, International Trade Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy Industry The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability.
Responsible Officer who filed this communication report:	An Van Gerven
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.